Characteristics and outcomes of SARS-CoV-2 infection in Victorian children at a tertiary paediatric hospital.
COVID-19
general paediatrics
infectious disease
Journal
Journal of paediatrics and child health
ISSN: 1440-1754
Titre abrégé: J Paediatr Child Health
Pays: Australia
ID NLM: 9005421
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
10
08
2021
received:
17
03
2021
accepted:
17
09
2021
pubmed:
26
10
2021
medline:
5
4
2022
entrez:
25
10
2021
Statut:
ppublish
Résumé
Victoria experienced two 'waves' of COVID-19 between March and September 2020 and more cases than any other jurisdiction in Australia. Although world-wide reports of COVID-19 reflect that children are less likely to experience severe disease compared with adults, hospitalisations and deaths have been reported. We report testing and outcomes of children with SARS-CoV-2 infection presenting to a tertiary paediatric hospital in Melbourne. We conducted a prospective cohort study at The Royal Children's Hospital (RCH), including all children and adolescents (aged 0-18 years) who presented and were tested for SARS-CoV-2 over a 6-month period, between 21 March 2020, up to the 21 September 2020. Detailed epidemiological and clinical data were recorded. A total of 19 708 tests for SARS-CoV-2 were performed in 14 419 patients. One hundred and eighty patients tested positive for SARS-CoV-2 (1.2%). 110 (61%) were symptomatic, 60 (33%) were asymptomatic and 10 (6%) were pre-symptomatic. Close contacts of a positive case were associated with a higher risk of a testing positive for SARS-CoV-2 (120/2027 (6%) vs. 60/14589 (0.4%), RD 5.5 (95% CI 4.5 to 6.5), P < 0.001). Eighteen (10%) SARS-CoV-2-positive patients were admitted to hospital with one patient requiring intensive care. All patients recovered fully with no deaths. In Victorian children presenting to a tertiary hospital, SARS-CoV-2 infection caused predominantly mild or asymptomatic infection, with most children not requiring hospitalisation.
Identifiants
pubmed: 34693586
doi: 10.1111/jpc.15786
pmc: PMC8662161
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
618-623Informations de copyright
© 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
Références
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Nat Immunol. 2021 Jan;22(1):25-31
pubmed: 33154590
Commun Med (Lond). 2021 Nov 15;1:47
pubmed: 35602234
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Acta Paediatr. 2020 Oct;109(10):1948-1955
pubmed: 32557789
JAMA. 2020 Apr 14;323(14):1335
pubmed: 32181795
Arch Dis Child. 2020 Dec 1;:
pubmed: 33262177
BMJ. 2003 Jul 5;327(7405):36-40
pubmed: 12842956
Trop Med Int Health. 2021 Jan;26(1):115-119
pubmed: 33217116
JAMA Pediatr. 2020 Sep 01;174(9):868-873
pubmed: 32392288
JAMA. 2020 Jul 21;324(3):294-296
pubmed: 32511676
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Eur J Pediatr. 2020 Jul;179(7):1029-1046
pubmed: 32424745
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
Lancet Child Adolesc Health. 2020 Sep;4(9):669-677
pubmed: 32653054
JAMA Pediatr. 2020 Apr 8;:
pubmed: 32267485
Pediatrics. 2020 Dec;146(6):
pubmed: 32968031
Emerg Med Australas. 2020 Oct;32(5):801-808
pubmed: 32390285
Pediatrics. 2020 Sep;146(3):
pubmed: 32518171
Lancet Infect Dis. 2020 Nov;20(11):e276-e288
pubmed: 32818434
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853